Medicare Enrolled
Dr. Robert Ikeman, MD
Rheumatology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ikeman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ikeman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ikeman
Dr. Robert Ikeman is a rheumatology specialist in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ikeman performed 126,665 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ikeman received a total of $21,443 from 41 pharmaceutical and/or device companies across 1010 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ikeman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 19% volume in FL
$21,443 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 75668 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗126,665
Medicare services
Top 19% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
45,800 | $4 | $20 |
| Tocilizumab injection (Actemra) | 23,871 | $5 | $10 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
21,001 | $11 | $50 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
15,300 | $34 | $100 |
| Romosozumab injection (Evenity) for osteoporosis | 9,240 | $8 | $12 |
| Denosumab injection (Prolia/Xgeva) | 6,364 | $18 | $28 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,412 | $26 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,214 | $92 | $289 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
386 | $11 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
344 | $50 | $100 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
130 | $101 | $550 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $127 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
85 | $64 | $200 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
72 | $48 | $160 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
70 | $7 | $50 |
| Injection, methylprednisolone acetate, 40 mg | 69 | $6 | $14 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
62 | $9 | $38 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
54 | $50 | $125 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
46 | $22 | $150 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
20 | $12 | $34 |
| New patient office visit, complex (60-74 min) | 19 | $157 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
30.9% high complexity
67.9% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$21,443
Total received (2018-2024)
Avg $3,063/year across 7 years
Top 21% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,010
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,757
2023
$3,270
2022
$2,383
2021
$1,873
2020
$2,144
2019
$4,207
2018
$4,809
Payments by company (2024)
Amgen Inc.
$531
Novartis Pharmaceuticals Corporation
$478
ABBVIE INC.
$419
E.R. Squibb & Sons, L.L.C.
$251
AstraZeneca Pharmaceuticals LP
$213
GENZYME CORPORATION
$170
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
GlaxoSmithKline, LLC.
$150
UCB, Inc.
$115
Lilly USA, LLC
$57
Kiniksa Pharmaceuticals International, plc
$56
Radius Health, Inc.
$51
Janssen Scientific Affairs, LLC
$32
PFIZER INC.
$23
Janssen Biotech, Inc.
$18
Almatica Pharma LLC
$18
Genentech USA, Inc.
$15
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,131
Novartis Pharmaceuticals Corporation
$2,311
PFIZER INC.
$2,195
ABBVIE INC.
$1,491
AbbVie, Inc.
$1,319
Lilly USA, LLC
$1,206
GlaxoSmithKline, LLC.
$1,006
UCB, Inc.
$925
AbbVie Inc.
$910
E.R. Squibb & Sons, L.L.C.
$852
Janssen Biotech, Inc.
$836
AstraZeneca Pharmaceuticals LP
$769
Genentech USA, Inc.
$608
Radius Health, Inc.
$603
Horizon Therapeutics plc
$534
GENZYME CORPORATION
$526
Boehringer Ingelheim Pharmaceuticals, Inc.
$485
Celgene Corporation
$274
Janssen Scientific Affairs, LLC
$269
Aurinia Pharma U.S., Inc.
$135
Fidia Pharma USA Inc.
$108
Mallinckrodt Hospital Products Inc.
$101
Horizon Pharma plc
$98
Actelion Pharmaceuticals US, Inc.
$95
Flexion Therapeutics, Inc.
$87
Sobi, Inc
$81
Kiniksa Pharmaceuticals, Ltd.
$66
Alexion Pharmaceuticals, Inc.
$64
Kiniksa Pharmaceuticals International, plc
$56
Mallinckrodt Enterprises LLC
$47
Mallinckrodt LLC
$46
Mylan Institutional Inc.
$33
SOBI, INC
$30
Fresenius Kabi USA, LLC
$26
Pacira Therapeutics, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$20
Oxford Immunotec USA Inc
$19
Almatica Pharma LLC
$18
Ultragenyx Pharmaceutical Inc.
$15
FIDIA PHARMA USA INC.
$13
Ironwood Pharmaceuticals, Inc
$13
Top 3 companies account for 35.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · DUZALLO · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · HYMOVIS · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Prolia · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · TSPOT TB TEST · Tavneos · Tymlos · Uloric · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
25
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ikeman is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ikeman experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Ikeman performed 45,800 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ikeman receive payments from pharmaceutical companies?
Yes. Dr. Ikeman received a total of $21,443 from 41 companies across 1,010 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ikeman's costs compare to other rheumatologists in Sarasota?
Dr. Ikeman's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ikeman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Sarasota
Browse rheumatologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology